Recommended Articles
Fundraising

Cent Raises $15 Million Series A to Scale AI-Led Preventive Health Screening

By Angeled · October 28, 2026 · Fundraising
Cent Raises $15 Million Series A to Scale AI-Led Preventive Health Screening
Cent Raises $15 Million Series A to Scale AI-Led Preventive Health Screening

On October 28, 2026, Bengaluru-based Cent announced a $15 million Series A round to expand its AI-led early-detection platform. The round, a mix of equity and debt, was co-led by Blume Ventures and existing investor South Park Commons. Individual investors include Arun Sarin, former CEO of Vodafone, and Srinivas Narayanan, former chief technology officer for business-to-business applications at OpenAI, along with Sharath Narayana, Krishna Sridhar, and Aprameya Radhakrishna.

Alongside the funding, Cent announced an acquisition: it has acquired Medsee, an AI-powered radiology reporting workflow platform built for qualified medical professionals and founded by Chitra Singh. The deal pairs Cent's screening centres with a reporting engine that can standardise and accelerate radiology reports as scan volumes rise.

What Cent does

Cent was founded in 2025 by Shashank ND, co-founder of Practo, one of India's best-known health technology companies; Anshul Khandelwal, formerly chief marketing officer of Ola Electric; and Arpit Garg, formerly product head at Lenskart. The team combines health-tech, consumer-brand, and product experience — a useful mix for a company that must win both clinical trust and consumer demand.

The company is building a preventive healthcare platform that combines purpose-built hardware, AI-driven radiology and diagnostics, and bioinformatics, with the aim of spotting health risks before they turn into serious conditions. Its flagship offering, the Cent Check, is a preventive screening session of about two hours that combines full-body MRI, low-dose CT, DEXA bone-density scanning, ECG and echocardiography, and more than 100 biomarkers, followed by a six-month checkpoint and up to four doctor consultations. The idea is to be more comprehensive than a routine health check-up, which typically relies on a limited set of tests.

Cent runs its own centres in Bengaluru, Mumbai, and Delhi, and says it has completed about 10,000 preventive whole-body scans so far. It aims to reach 10 million scans by 2035 and has set a long-term goal of helping save one million lives through early detection. One in four people screened over the past year had a finding that needed medical attention, according to the company's reporting of its results — a figure that, if sustained, underscores both the opportunity and the responsibility of screening healthy-seeming people.

Why the Medsee acquisition matters

Acquiring Medsee at the same time as raising the round is a deliberate signal. Screening at scale creates a reporting bottleneck: every scan generates images and data that must be read, written up, and explained to a patient and their doctor. If reports are slow, inconsistent, or hard to understand, the whole model breaks down — patients lose confidence, doctors lose time, and the data needed to train better detection models never gets standardised.

Medsee's AI-assisted radiology reporting workflow is designed to speed and standardise report drafting for qualified medical professionals. For Cent, that means faster turnaround as volumes grow, more consistent reports across centres, and cleaner structured data to feed its detection models. For investors, it shows a company thinking about the full stack — not just acquiring customers for scans, but owning the workflow that turns a scan into a clinical decision.

Preventive health: a global race with a local price point

Cent is entering a market that has attracted enormous capital globally. In the US, full-body MRI screening companies have raised hundreds of millions of dollars, and established players sell scans at prices far above Cent's. Cent's annual check starts at roughly ₹23,500, about $250 at current exchange rates — a fraction of the cost of a comparable US offering. That price point is central to its thesis: preventive screening only changes population health if it is affordable at scale, not just available to the wealthy.

Why it matters for founders and investors

For founders, Cent illustrates two useful patterns. First, a credible founder-market fit story — a Practo co-founder returning to health care with a preventive thesis — still opens doors, but it does not close a round on its own; the round was paired with traction (10,000 scans), a product acquisition, and a concrete scale target. Second, the equity-plus-debt structure is a reminder that not every Series A is pure equity. Debt can fund hardware-heavy expansion, but it also creates repayment obligations that a software-only startup would not face.

For investors, Cent is a bet that preventive health is a data business as much as a services business. If the company reaches even a fraction of its 10-million-scan goal, the standardised scan data it accumulates could support clinical research and better detection models — an asset that compounds. If it cannot maintain clinical quality and trust at scale, that same data becomes a liability. The next milestones to watch are centre expansion, repeat-scan rates, and whether doctors and hospitals begin to treat Cent's reports as a standard part of preventive care rather than a premium add-on.

Angeled.com connects founders with investors.

Source: https://businessconnectindia.in/cent-raises-15-million-ai-preventive-healthcare/

Read Next